Abstract
Confirming the absence of the placebo response has been the bane of researchers throughout the ages. Thus, the gold standard of research methodology is the evidence for a treatment modality provided by a prospective randomized controlled trial. The “control” arm of a trial is the arm in which the placebo has been administered. Increasing evidence from basic science and clinical research is pointing to the fact that the placebo response may have some biological basis that can translate into enduring therapeutic benefit. Have our placebo-controlled trials simply compared one treatment effect to the treatment effect of the “placebo”? Thus, the “δ” is relative treatment effect; perhaps this may provide some insight as to why some treatment response is low compared to a relatively strong placebo response. How can we use this knowledge to create more robust clinical designs that help establish true treatment effect? This article aims to provide an overview of the contemporary insight into the placebo response.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Beecher HK: The powerful placebo. J Am MedAssoc. 1955;159:1602–1606.
Harden RN, Rogers DS, Fink K, Gracely R: Controlled trial of ketorolac in tension-type headache. Neurology 1998; 50: 507–9
Haygarth J: Of the Imagination, as a Cause and as a Cure of Disorders of the Body; Exemplfied by Fictitious Tractors, and Epidemical Convulsions. Bath:Crutwell, 1801]
de Craen AJ, Kaptchuk TJ, Tijssen JG, Kleijnen J: Placebos and placebo effects in medicine: historical overview. J R Soc Med. 1999; 92: 511–5
Shapiro AK: A contribution to the history of the placebo effect. Behav Sci 1960; 5: 109–35
Ambersom JB, McMahon BT, Pinner MA: A clinical trial of sanocrysin in pulmonary tuberculosis. Am Rev Tuberculosis 1931; 24: 401–35
Diehl HS, Baker AB, Cowan DW: Cold vaccines: an evaluation based on a controlled study. JAMA 1938; 111: 1168–73
Dunlop DM, Henderson TL, Inch RS: A survey of 17,301 prescriptions on from E.C. 10. Br Med J 1952; 1: 292–5
Kefauver-Harris: Kefauver-Harris Amendments of October 10, 1962 to Food and Drug and Cosmetic Act. Code Federal Regulation. Code Federal Regulation 1962; 1
Federal Register: Federal Register. Federal Register 1970; 35: 7250
Colloca L, Benedetti F: Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci 2005; 6: 545–52
Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I: Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses. Journal of Neuroscience 2003; 23: 4315–23
•• Benedetti F: Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments. Annual Review of Pharmacology and Toxicology 2008; 48: 33–60. This is an outstanding review of the scientific basis of the placebo and placebo-related effects in all organ system, clearly set out, with diagrams and tables that enhance the key point.
Stewart-Williams S, Podd J: The Placebo Effect: Dissolving the Expectancy Versus Conditioning Debate. Psychological Bulletin. 2004; 130: 324–40
Ader R, Kelly K, Moynihan JA, Grota LJ, Cohen N: Conditioned Enhancement of Antibody Production Using Antigen as the Unconditioned Stimulus. Brain, Behavior, and Immunity 1993; 7: 334–43
Pacheco-Lopez G, Engler H, Niemi MB, Schedlowski M: Expectations and associations that heal: Immunomodulatory placebo effects and its neurobiology. Brain, Behavior, and Immunity 2006; 20: 430–46
Giang DW, Goodman AD, Schiffer RB, Mattson DH, Petrie M, Cohen N, Ader R: Conditioning of cyclophosphamide-induced leukopenia in humans. Journal of Neuropsychiatry and Clinical Neurosciences 1996; 8: 194–201
•• Doherty M, Dieppe P: The “placebo” response in osteoarthritis and its implications for clinical practice. Osteoarthritis and Cartilage 2009; 17: 1255–62. This excellent review of the basis of the placebo response provides important historical perspective, and more importantly, the clinical relevance of the placebo response.
Jurko S, Rozinaj G. High Resolution of the ECG Signal by Polynomial Approximation. Radioengineering 2006; 15(1):32–37
Clauw DJ, Witter J: Pain and rheumatology: Thinking outside the joint. Arthritis Rheum 2009; 60 (2): 321–4.
Wolfe D, Mata M, Fink DJ: A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther 2009; 16: 455–60.
Chen ALC, Chen TJH, Waite RL, Reinking J, Tung HL, Rhoades P, Downs BW, Braverman E, Braverman D, Kerner M, Blum SH, DiNubile N, Smith D, Oscar-Berman M, Prihoda TJ, Floyd JB, O’Brien D, Liu HH, Blum K: Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions. Medical Hypotheses 2009; 72: 14–22
Van Meurs JB, Uitterlinden AG, Stolk L, Kerkhof HJ, Hofman A, Pols HA, Bierma-Zeinstra SM: A functional polymorphism in the catechol-O-methyltransferase gene is associated with osteoarthritis-related pain. Arthritis Rheum. 2009; 60 (2): 628–9.
Disclosures
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Williams, K.A., Harden, N. Managing the Placebo Effect: Enhancing the Signal-to-Noise Ratio. Curr Pain Headache Rep 15, 35–38 (2011). https://doi.org/10.1007/s11916-010-0162-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11916-010-0162-2